Cardiovascular Genetic Risk Testing for Targeting Statin Therapy in the Primary Prevention of Atherosclerotic Cardiovascular Disease: A Cost-Effectiveness Analysis.

Jarmul, Jamie

Cardiovascular Genetic Risk Testing for Targeting Statin Therapy in the Primary Prevention of Atherosclerotic Cardiovascular Disease: A Cost-Effectiveness Analysis. [electronic resource] - Circulation. Cardiovascular quality and outcomes 04 2018 - e004171 p. digital

Publication Type: Journal Article; Research Support, N.I.H., Extramural

1941-7705

10.1161/CIRCOUTCOMES.117.004171 doi


Aged
Atherosclerosis--blood
Clinical Decision-Making
Cost-Benefit Analysis
Decision Support Techniques
Decision Trees
Drug Costs
Dyslipidemias--blood
Female
Gene Expression Profiling--economics
Genetic Association Studies
Genetic Markers
Genetic Predisposition to Disease
Health Status
Humans
Hydroxymethylglutaryl-CoA Reductase Inhibitors--economics
Lipids--blood
Male
Markov Chains
Middle Aged
Models, Economic
Phenotype
Polymorphism, Single Nucleotide
Predictive Value of Tests
Primary Prevention--economics
Quality-Adjusted Life Years
Risk Assessment
Risk Factors
Time Factors
Treatment Outcome